|
MFAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46650025456552E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.24470000365073E-08 |
| Normal-vs-Stage2 |
2.37999999999072E-05 |
| Normal-vs-Stage3 |
3.24330007295259E-10 |
| Normal-vs-Stage4 |
7.09066139137349E-12 |
| Stage1-vs-Stage2 |
9.835000E-01 |
| Stage1-vs-Stage3 |
1.350040E-01 |
| Stage1-vs-Stage4 |
3.956400E-03 |
| Stage2-vs-Stage3 |
3.067800E-01 |
| Stage2-vs-Stage4 |
4.656300E-02 |
| Stage3-vs-Stage4 |
1.789160E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.34000049839744E-10 |
| Normal-vs-AfricanAmerican |
2.177100E-04 |
| Normal-vs-Asian |
9.96690000000244E-05 |
| Caucasian-vs-AfricanAmerican |
7.060200E-01 |
| Caucasian-vs-Asian |
3.064800E-01 |
| AfricanAmerican-vs-Asian |
7.410200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.97020194498054E-11 |
| Normal-vs-Female |
2.82930001649362E-09 |
| Male-vs-Female |
5.750000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.19079999883721E-08 |
| Normal-vs-Age(41-60Yrs) |
1.82370000212373E-08 |
| Normal-vs-Age(61-80Yrs) |
1.62320157315321E-11 |
| Normal-vs-Age(81-100Yrs) |
1.66263999999972E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.864600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.423700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.022450E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.706300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.169590E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.347400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.294420E-02 |
| Classical-VS-Follicular |
1.021530E-04 |
| Classical-VS-Other |
6.680200E-02 |
| Classical-VS-Normal |
8.23229999724617E-08 |
| Tall-VS-Follicular |
8.878800E-01 |
| Tall-VS-Other |
6.848200E-01 |
| Tall-VS-Normal |
3.85139997671757E-09 |
| Follicular-VS-Other |
6.700800E-01 |
| Follicular-VS-Normal |
7.56340545748913E-11 |
| Other-VS-Normal |
2.202600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.33609995184503E-09 |
| Normal-vs-N1 |
4.71459538076147E-11 |
| N0-vs-N1 |
1.412180E-02 |
|
|
